IMMX
Immix Biopharma Inc
10.10$
+4.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | +122.7% | +675.4% | +1.9% | +6.6% | – | – | +34.9% | – | – | +44.3% | – | – | |
| – | – | -1,496.4% | – | – | – | -222.9% | – | – | – | – | – | – | |
| – | +47.2% | +4.8% | -31.5% | +99.9% | -69.1% | +43.7% | +101.1% | +15.4% | +24.9% | +4.4% | -10.8% | – | |
| – | -5.9% | +2.9% | +5.8% | +19.0% | +22.5% | -25.0% | +1.4% | +12.1% | +67.8% | -6.6% | +47.7% | – | |
| – | +18.8% | +4.0% | -15.9% | +57.3% | -32.6% | -6.1% | +43.5% | +14.1% | +42.2% | -0.8% | +15.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +18.8% | +9.3% | +16.2% | +8.5% | -3.2% | -8.9% | -9.2% | -13.4% | +45.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.